Literature DB >> 8093485

A simple clinical staging system that predicts progression to AIDS using CD4 count, oral thrush, and night sweats.

L Rabeneck1, M M Crane, J M Risser, C E Lacke, N P Wray.   

Abstract

OBJECTIVE: To develop a simple clinical staging system based on CD4 count and clinical variables that predicts progression to AIDS in HIV-infected non-AIDS patients.
DESIGN: Retrospective cohort study.
SETTING: A primary care outpatient clinic for HIV-infected patients at a VA Medical Center. PATIENTS: One hundred seventy-six HIV-infected non-AIDS patients seen at the Houston VA Special Medicine Clinic between January 1986 and December 1990 and followed for a mean of 22 months. Fifty-four patients (31%) progressed to AIDS during follow-up. MEASUREMENTS: The medical records were reviewed, and data corresponding to the initial (baseline) clinic visit and subsequent six-month visits were extracted. MAIN
RESULTS: "Predictive" baseline variables (i.e., those associated with progression to AIDS) were first identified and then examined in Cox proportional hazards modeling. In the final model, CD4 category, oral thrush, and night sweats made significant independent contributions. A three-stage prognostic system was constructed by assigning points to the three variables: CD4 > 500 cells/mm3 = 0; 500 > or = CD4 > or = 200 = 1; CD4 < 200 = 2; presence of oral thrush = 1; presence of night sweats = 1. Stages were assigned as follows: stage I = 0 points, stage II = 1-2 points, and stage III = 3-4 points. The proportions of patients who progressed to AIDS were: stage I, 6/39 (15%); stage II, 31/106 (29%); and stage III, 17/31 (55%).
CONCLUSIONS: These results demonstrate that simple, clinically sensible prognostic staging systems that predict progression to AIDS can be constructed using CD4 count and clinical variables.

Entities:  

Mesh:

Year:  1993        PMID: 8093485     DOI: 10.1007/bf02600284

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  16 in total

Review 1.  Natural history of HIV infection.

Authors:  A R Moss; P Bacchetti
Journal:  AIDS       Date:  1989-02       Impact factor: 4.177

2.  Toward a better classification system for HIV infection.

Authors:  R R Redfield; E C Tramont
Journal:  N Engl J Med       Date:  1989-05-25       Impact factor: 91.245

3.  Lymphadenopathy in asymptomatic patients seropositive for HIV.

Authors:  D Osmond; R Chaisson; A Moss; P Bacchetti; W Krampf
Journal:  N Engl J Med       Date:  1987-07-23       Impact factor: 91.245

4.  The natural history of HIV-1 infection: staging classifications of disease.

Authors:  R A Royce; R S Luckmann; R E Fusaro; W Winkelstein
Journal:  AIDS       Date:  1991-04       Impact factor: 4.177

5.  Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome.

Authors:  R S Klein; C A Harris; C B Small; B Moll; M Lesser; G H Friedland
Journal:  N Engl J Med       Date:  1984-08-09       Impact factor: 91.245

6.  Progression to AIDS and predictors of AIDS in seroprevalent and seroincident cohorts of homosexual men.

Authors:  M T Schechter; K J Craib; T N Le; B Willoughby; B Douglas; P Sestak; J S Montaner; M S Weaver; K D Elmslie; M V O'Shaughnessy
Journal:  AIDS       Date:  1989-06       Impact factor: 4.177

7.  Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Centers for Disease Control, U.S. Department of Health and Human Services.

Authors: 
Journal:  Ann Intern Med       Date:  1986-08       Impact factor: 25.391

8.  A clinical-severity staging system for patients with lung cancer.

Authors:  A R Feinstein; C K Wells
Journal:  Medicine (Baltimore)       Date:  1990-01       Impact factor: 1.889

9.  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

Authors:  J L Fahey; J M Taylor; R Detels; B Hofmann; R Melmed; P Nishanian; J V Giorgi
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

View more
  14 in total

Review 1.  Human genetic susceptibility to Candida infections.

Authors:  Theo S Plantinga; Melissa D Johnson; William K Scott; Leo A B Joosten; Jos W M van der Meer; John R Perfect; Bart Jan Kullberg; Mihai G Netea
Journal:  Med Mycol       Date:  2012-06-04       Impact factor: 4.076

2.  Predicting progression to AIDS. An evaluation of two approaches.

Authors:  L Rabeneck; P M Hartigan; I W Huang; J Souchek; N P Wray
Journal:  J Gen Intern Med       Date:  1996-10       Impact factor: 5.128

Review 3.  Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis.

Authors:  P L Fidel
Journal:  Adv Dent Res       Date:  2011-04

4.  Genetic variation of innate immune genes in HIV-infected african patients with or without oropharyngeal candidiasis.

Authors:  Theo S Plantinga; Omar J M Hamza; Janet A Willment; Bart Ferwerda; Nicole M D van de Geer; Paul E Verweij; Mecky I N Matee; Kathy Banahan; Luke A J O'neill; Bart-Jan Kullberg; Gordon D Brown; André J A M van der Ven; Mihai G Netea
Journal:  J Acquir Immune Defic Syndr       Date:  2010-09       Impact factor: 3.731

Review 5.  Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents.

Authors:  Sahar Hasim; Jeffrey J Coleman
Journal:  Future Med Chem       Date:  2019-04-17       Impact factor: 3.808

6.  Evaluating the quality of life associated with rifabutin prophylaxis for Mycobacterium avium complex in persons with AIDS: combining Q-TWiST and multiattribute utility techniques.

Authors:  D A Revicki; K N Simpson; A W Wu; R L LaVallee
Journal:  Qual Life Res       Date:  1995-08       Impact factor: 4.147

7.  Skin and Mucocutaneous Manifestations: Useful Clinical Predictors of HIV/AIDS.

Authors:  Shashi Chopra; Usha Arora
Journal:  J Clin Diagn Res       Date:  2012-12-15

8.  Candida albicans Cannot Acquire Sufficient Ethanolamine from the Host To Support Virulence in the Absence of De Novo Phosphatidylethanolamine Synthesis.

Authors:  Sarah E Davis; Robert N Tams; Norma V Solis; Andrew S Wagner; Tian Chen; Joseph W Jackson; Sahar Hasim; Anthony E Montedonico; Justin Dinsmore; Timothy E Sparer; Scott G Filler; Todd B Reynolds
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

9.  In vitro susceptibility of 137 Candida sp. isolates from HIV positive patients to several antifungal drugs.

Authors:  S Magaldi; S Mata; C Hartung; G Verde; L Deibis; Y Roldán; C Marcano
Journal:  Mycopathologia       Date:  2001       Impact factor: 3.785

10.  Recent pattern of Co-infection amongst HIV seropositive individuals in tertiary care hospital, Kolkata.

Authors:  Kallol Saha; Rushna Firdaus; Poonam Santra; Jyotirmoy Pal; Arnab Roy; Mihir K Bhattacharya; Sekhar Chakrabarti; Provash C Sadhukhan
Journal:  Virol J       Date:  2011-03-14       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.